Clinical risk and monitoring essentials of tonifying Chinese patent medicine
|更新时间:2025-12-10
|
Clinical risk and monitoring essentials of tonifying Chinese patent medicine
“In the field of traditional Chinese patent medicines and simple preparations, experts have established a database of Fuzheng traditional Chinese patent medicines and simple preparations to deeply explore the clinical use risks and monitoring points, providing guidance for rational drug use.”
SUN Huan,ZHAI Qiaoli,XU Jie,et al.Clinical risk and monitoring essentials of tonifying Chinese patent medicine[J].ZHONGGUO YAOFANG,2025,36(23):2974-2977.
SUN Huan,ZHAI Qiaoli,XU Jie,et al.Clinical risk and monitoring essentials of tonifying Chinese patent medicine[J].ZHONGGUO YAOFANG,2025,36(23):2974-2977. DOI: 10.6039/j.issn.1001-0408.2025.23.16.
Clinical risk and monitoring essentials of tonifying Chinese patent medicine
Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province (2024 Edition)
Pharmaceutical care for a patient with atrial flutter, atrial fibrillation, placenta praevia hemorrhage and thrombocytopenia-threatened abortion after operation of congenital heart disease
Research advance of population pharmacokinetics of imipenem-cilastatin in special status populations
Use of Severe ADR-inducing Drugs in Special Population in Our Hospital Guided by the Detailed Quantitative Scoring Rules of Quick Guide for Drug Evaluation and Selection in Chinese Medical Institutions
Related Author
FU Wei
ZHAO Linlin
PANG Liangfang
JIN Fan
LIU Maochang
LU Yuanyuan
QUAN Shuyan
WANG Qing
Related Institution
Dept. of Clinical Pharmacy, General Hospital of Central Theater Command
Dept. of Pharmacy, Women and Children’s Hospital of Hubei Province
Dept. of Pharmacy, Wuhan Children’s Hospital
Dept. of Pharmacy, Yichang Women and Children’s Hospital
Dept. of Pharmacy, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology